Leading 10 corporate institutions in infectious disease
The leading 10 corporate institutions ranked by total article share (Share) in infectious disease from 2015 to 2020. Also listed are each institution's total infectious disease article count (Count), proportion of infectious disease Share relative to total Share (Infectious disease %), and percentage of internationally collaborative articles (International articles %) in the field 2015–20.
* Click on column headers to sort
| 1 | GlaxoSmithKline plc. (GSK) | United Kingdom (UK) | 27.60 | 87 | 26.5% | 79.3% |
| 2 | Merck & Co., Inc. | United States of America (USA) | 19.81 | 42 | 11.2% | 40.5% |
| 3 | Novartis International AG | Switzerland | 12.57 | 35 | 7.0% | 80.0% |
| 4 | F. Hoffmann-La Roche AG | Switzerland | 12.55 | 37 | 4.1% | 62.2% |
| 5 | Johnson & Johnson | United States of America (USA) | 10.25 | 39 | 15.4% | 84.6% |
| 6 | Gilead Sciences, Inc. | United States of America (USA) | 9.99 | 30 | 65.6% | 46.7% |
| 7 | AstraZeneca plc | United Kingdom (UK) | 8.37 | 30 | 5.1% | 76.7% |
| 8 | Vir Biotechnology, Inc. | United States of America (USA) | 4.95 | 24 | 90.3% | 95.8% |
| 9 | Sanofi | France | 4.76 | 23 | 11.6% | 65.2% |
| 10 | KWH Water B.V. | Netherlands | 4.25 | 11 | 26.2% | 45.5% |